{
    "title": "U.S. allows emergency use of first COVID-19 antibody drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8932039/U-S-allows-emergency-use-COVID-19-antibody-drug.html",
    "date": "2020-11-10",
    "keywords": [
        "drug",
        "treatment",
        "antibody",
        "emergency",
        "use",
        "covid19",
        "age",
        "eua",
        "bamlanivimab",
        "government",
        "risk",
        "illness",
        "administration",
        "authorization",
        "regeneron",
        "fda",
        "manufacturing",
        "plant",
        "beasley",
        "monday",
        "food",
        "cos",
        "trial",
        "infusion",
        "need",
        "hospitalization",
        "room",
        "class",
        "biotech",
        "case",
        "copy",
        "body",
        "inc",
        "president",
        "coronavirus",
        "disease",
        "expert",
        "dr",
        "anthony",
        "fauci",
        "recovery",
        "house",
        "statement",
        "decision",
        "milestone",
        "dualantibody",
        "anyone",
        "mildtomoderate",
        "health",
        "condition",
        "oxygen",
        "therapy",
        "study",
        "distributor",
        "amerisourcebergen",
        "outofpocket",
        "medicine",
        "healthcare",
        "fee",
        "end",
        "world",
        "year",
        "beginning",
        "firstquarter",
        "supply",
        "online",
        "party",
        "review",
        "substance",
        "companys",
        "jersey",
        "oct",
        "branchburg",
        "inspection",
        "november",
        "twoantibody",
        "cocktail",
        "singleantibody",
        "indianapolis",
        "drugmaker",
        "trading",
        "reporting",
        "chander",
        "bengaluru",
        "editing",
        "brown",
        "stephen"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}